Moreover, our results correlate with data obtained from myofibroblasts isolated from other pathological tissues, namely plaque tissue from Peyronie’s disease and forearm skin of patients with diffuse subset scleroderma, where expression of COL1A1 is also decreased after VP treatment37,39. This evidence concerns the gene COL1A1 and Peyronie disease.